Device Trial Radar · NCT03511313
Renal Denervation With Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary Hypertension
Last checked: Nov 20, 2026Latest source record: Apr 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
264
Planned (sponsor's estimate)
Start
Apr 11, 2018
Primary completion
Jun 2020
Study completion Sep 2020
Sponsor
- Lead sponsor
- Synaptic Medical CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 27, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety and efficacy of renal denervation with sterile irrigated deflectable ablation catheter used in renal artery in primary hypertension in China.
Conditions
- Primary Hypertension
Interventions
Renal denervationDevice
After a renal angiography according to standard procedures, subjects are treated with renal denervation (with sterile irrigated deflectable ablation catheter in renal artery), if without renal anatomic abnormality not detected by Renal CT/CTA.
Renal angiographyDiagnostic test
A renal angiography according to standard procedure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in daytime average systolic blood pressure as measured by 24-hour Ambulatory Blood Pressure MonitoringTime frame: from baseline to 3 months post-procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Peking University First Hospital
Beijing, Beijing Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.